Back to top

Analyst Blog

Monsanto Company (MON - Analyst Report) reported improved results for the first quarter of fiscal 2014 (ended Nov 30, 2013), with year-over-year improvement in revenues and earnings. The company recorded adjusted earnings per share from continuing operations of 67 cents, beating the Zacks Consensus Estimate of 63 cents by 6.3%. Reported earnings were also more than 62 cents earned a year ago.

On an as-reported basis, the company reported earnings per share of 69 cents, improving from the year-ago earnings per share of 63 cents.

Revenues: First-quarter revenues of $3,143.0 million beat the Zacks Consensus Estimate of $3,091.0 million by 1.7%. Also, revenues increased 6.9% year over year.

On a segment basis, revenues from Seeds and Genomics decreased 4.5% year over year to $1.7 billion. The decrease was a result of reduction of corn acres in Latin America, which was partially offset by a rise in the soybean and corn business. Revenues from Agricultural Productivity increased 23.9% year over year to $1.5 billion buoyed by favorable demand.

Cost & Margins: Monsanto’s gross profit margin was 50% compared with 48% recorded in the earlier-year quarter. Operating expenses were recorded at $998.0 million, which was higher than $888.0 million in the year-ago quarter.

In the reported quarter, selling, general and administrative, and research and development expenses, as a percentage of net sales, were recorded at 19.0% and 13.0%, respectively.

Balance Sheet/Cash Flow: Exiting fiscal first-quarter 2014, Monsanto’s cash and cash equivalents were approximately $4.5 billion compared with $3.7 billion at the end of fiscal fourth quarter 2013. Long-term debt was $3.1 billion against $2.1 billion in the prior quarter.

In the reported quarter, cash flow from operations was $1.7 billion compared with $1.6 billion in the year-ago quarter. Total capital spending was roughly $303.0 million against $133.0 million spent in the quarter ended Nov 2012.

Outlook: Based on the improved performance, management has reaffirmed its expectations for fiscal 2014. Earnings per share are expected in the range of $5.00 to $5.20. On an as-reported basis, the company expects to earn $5.02 to $5.22 per share.  

Management also reaffirmed free cash flow in the range of $600.0 million to $800.0 million. Cash flow from operating activities is projected in the range of $2.9 billion to $3.3 billion.  

Other Stocks to Consider

Monsanto currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the industry include Gruma S.A.B. de CV (GMK - Snapshot Report), The Scotts Miracle-Gro Company (SMG - Snapshot Report) and The Andersons, Inc. (ANDE - Analyst Report). While Gruma S.A.B. and The Scotts carry a Zacks Rank #1 (Strong Buy), The Andersons holds a Zacks Rank #2 (Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
ERBA DIAGNO… ERB 3.71 +4.51%
BANCO DO BR… BDORY 14.45 +3.58%
WEATHERFORD… WFT 23.71 +3.40%
EQT MIDSTRE… EQM 97.64 +2.85%
MALLINCKROD… MNK 78.11 +2.84%